scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1018459436 |
P356 | DOI | 10.4248/BR201301006 |
P932 | PMC publication ID | 4472095 |
P698 | PubMed publication ID | 26273494 |
P5875 | ResearchGate publication ID | 236735410 |
P50 | author | Mary L. Bouxsein | Q66753654 |
P2093 | author name string | Douglas J DiGirolamo | |
Marie-Claude Faugere | |||
Brian C Goh | |||
Vandana Singhal | |||
P2860 | cites work | Domains of the growth hormone receptor required for association and activation of JAK2 tyrosine kinase | Q24317435 |
Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor | Q28288032 | ||
Growth hormone regulation of sex-dependent liver gene expression | Q28302526 | ||
Growth hormone promoted tyrosyl phosphorylation of growth hormone receptors in murine 3T3-F442A fibroblasts and adipocytes | Q28609968 | ||
Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase | Q28618942 | ||
Human growth hormone (GH) receptor is characterized as the 134-kilodalton tyrosine-phosphorylated protein activated by GH treatment in IM-9 cells | Q30464723 | ||
Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization | Q74742272 | ||
Osteoblast-specific expression of insulin-like growth factor-1 in bone of transgenic mice induces insulin-like growth factor binding protein-5 | Q81552004 | ||
Evolution of Class I cytokine receptors | Q33291265 | ||
Growth hormone pulse-activated STAT5 signalling: a unique regulatory mechanism governing sexual dimorphism of liver gene expression | Q33884070 | ||
Bone formation and factors affecting this process | Q33936563 | ||
Pulsatility of growth hormone (GH) signalling in liver cells: role of the JAK-STAT5b pathway in GH action | Q34030528 | ||
Insulin-like growth factor regulates peak bone mineral density in mice by both growth hormone-dependent and -independent mechanisms | Q34074077 | ||
The somatomedin hypothesis: 2001. | Q34131694 | ||
The role of GH/IGF-I-mediated mechanisms in sex differences in cortical bone size in mice | Q34592104 | ||
Aromatase activity and bone homeostasis in men. | Q35973043 | ||
Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I | Q36232491 | ||
Activation of growth hormone receptors by growth hormone and growth hormone antagonist dimers: insights into receptor triggering | Q36512432 | ||
Differentiation and proliferation of periosteal osteoblast progenitors are differentially regulated by estrogens and intermittent parathyroid hormone administration | Q36976441 | ||
Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism | Q37338980 | ||
Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription | Q38294444 | ||
Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone. | Q38298544 | ||
Synergistic action of hepatocyte nuclear factors 3 and 6 on CYP2C12 gene expression and suppression by growth hormone-activated STAT5b. Proposed model for female specific expression of CYP2C12 in adult rat liver | Q38309675 | ||
Insulin-like growth factor I inhibits the transcription of collagenase 3 in osteoblast cultures | Q38342073 | ||
Structure and evolution of the growth hormone gene family | Q40151142 | ||
The effects of cytokines and growth factors on osteoblastic cells | Q40957410 | ||
The membrane proximal region of the cytoplasmic domain of the growth hormone receptor is involved in the activation of Stat 3 | Q41313217 | ||
Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription | Q41438563 | ||
Growth hormone stimulates the tyrosine phosphorylation of 42- and 45-kDa ERK-related proteins | Q41635589 | ||
Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblast-like cells and human osteogenic sarcoma cells | Q41653974 | ||
Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH. | Q41692337 | ||
Insulin-like growth factor-I and insulin-like growth factor-II induce c-fos in mouse osteoblastic cells | Q41739461 | ||
Interactions between growth hormone, insulin-like growth factor I, and basic fibroblast growth factor in melanocyte growth | Q42472027 | ||
Insulin receptor substrate-1-mediated enhancement of growth hormone-induced mitogen-activated protein kinase activation | Q42492692 | ||
Growth hormone induces a DNA binding factor related to the interferon-stimulated 91-kDa transcription factor | Q42801590 | ||
Stimulation by growth hormone of MAP kinase activity in 3T3-F442A fibroblasts | Q42820892 | ||
Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements | Q42830324 | ||
The skeletal structure of insulin-like growth factor I-deficient mice | Q44588867 | ||
Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: a potential candidate for fixing IGF-II in human bone | Q46149499 | ||
Mode of growth hormone action in osteoblasts. | Q50669707 | ||
Conditional mutagenesis in mice with heat shock promoter-driven cre transgenes. | Q52169941 | ||
Growth hormone (GH) induction of tyrosine phosphorylation and activation of mitogen-activated protein kinases in cells transfected with rat GH receptor cDNA. | Q55037373 | ||
Growth hormone binds to a single high affinity receptor site on mouse osteoblasts: modulation by retinoic acid and cell differentiation | Q61480407 | ||
Expression of functional growth hormone receptors in cultured human osteoblast-like cells | Q61480412 | ||
Growth Hormone Induction of Hepatic Serine Protease Inhibitor 2.1 Transcription Is Mediated by a Stat5-related Factor Binding Synergistically to Two γ-Activated Sites | Q61585384 | ||
Growth hormone is mitogenic for fetal mouse osteoblasts but not for undifferentiated bone cells | Q68293261 | ||
Activation of growth hormone receptor delivers an antiapoptotic signal: evidence for a role of Akt in this pathway | Q73222433 | ||
Involvement of STAT5 (signal transducer and activator of transcription 5) and HNF-4 (hepatocyte nuclear factor 4) in the transcriptional control of the hnf6 gene by growth hormone | Q73447619 | ||
Insulin-like growth factor I receptor signaling--overlapping or redundant pathways? | Q73621905 | ||
Multiple extracellular signals promote osteoblast survival and apoptosis | Q73635417 | ||
Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation | Q73941872 | ||
The effects of IGF-I and IGF-II on proliferation and differentiation of human osteoblasts and interactions with growth hormone | Q74501677 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | osteoblast | Q917177 |
sexual dimorphism | Q181497 | ||
P304 | page(s) | 85-97 | |
P577 | publication date | 2013-03-29 | |
P1433 | published in | Bone research | Q26842189 |
P1476 | title | Osteoblast-restricted Disruption of the Growth Hormone Receptor in Mice Results in Sexually Dimorphic Skeletal Phenotypes | |
P478 | volume | 1 |
Q36968228 | Bone and skeletal muscle: neighbors with close ties |
Q37628177 | Combined Effects of Androgen and Growth Hormone on Osteoblast Marker Expression in Mouse C2C12 and MC3T3-E1 Cells Induced by Bone Morphogenetic Protein |
Q99614370 | Effect of growth hormone on insulin signaling |
Q34543980 | Estrogens and Androgens in Skeletal Physiology and Pathophysiology |
Q57809722 | Golgi protein 73 and its diagnostic value in liver diseases |
Q54110794 | Growth Hormone Receptor Mutations Related to Individual Dwarfism. |
Q34437537 | Sex steroid actions in male bone |
Q39527508 | Skeletal effects of growth hormone and insulin-like growth factor-I therapy. |
Search more.